Exciting ENCY!

Encysive Pharma, (ENCY) whose stock price has just depreciated by 39%, might be the right stock to buy. Its stock went down because its competitor for the same type of drug just came out with their phase 3 results, and it met all its primary endpoints. However, I don't really think this will take any profits away from ENCY's bottom line. I still believe that the company has done a tremendous effort with their drug, Thelin and will continue to have success. I also believe that because this company already has a drug that has been approved by the FDA it will use the profits from that drug to offset any R&D expenses for other drugs in the future. Thelin is in phase 3 clinical trials and it is used to treat pulmonary arterial hypertension. I believe in this company and I hope to see the stock soar from these levels of $8.05 Price Target: $18